Master Acarbose (Precose) and Miglitol (Glyset) (Alpha Glucosidase Inhibitors) with Picmonic for Nursing RN

With Picmonic, facts become pictures. We've taken what the science shows - image mnemonics work - but we've boosted the effectiveness by building and associating memorable characters, interesting audio stories, and built-in quizzing.

Acarbose (Precose) and Miglitol (Glyset) (Alpha Glucosidase Inhibitors)

A-carbs-bus at Mug-toll
Picmonic
Acarbose (Precose) and miglitol (Glyset) are alpha glucosidase inhibitors used to help control blood glucose levels in diabetic patients. By inhibiting an intestinal enzyme that converts complex carbohydrates into digestible forms, these medications decrease the rate of carbohydrate digestion and absorption. This action decreases the rise of glucose levels caused by eating. These medications are indicated for patients with type 2 diabetes. Side effects include flatulence, cramps, diarrhea, and anemia. Since these drugs may cause liver damage, liver function tests should be monitored frequently. In the event of hypoglycemia, glucose (not sucrose) should be administered.
9 KEY FACTS
MECHANISMS
Alpha Glucosidase Inhibitors
Inhibiting-chains on Afro-guy with Glue-daisies

The enyzme alpha-glucosidase is responsible for breaking down oligosaccharides and complex carbohydrates into digestible monosaccharides. Acarbose and miglitol inhibit this enzyme and decrease the rate of carbohydrate digestion. Delaying carbohydrate digestion slows down carbohydrate absorption that causes increased glucose levels. Unlike other oral antidiabetics, the mechanism of acarbose and miglitol does not rely on the presence of insulin.

Delays Absorption of Carbohydrates
Carbs Delayed from Absorbing-sponge

Eating results in increased blood glucose levels. Acarbose and miglitol target the enzyme located in the intestines. These medications inhibit the digestion and absorption of carbohydrates. By delaying carbohydrate absorption, these drugs decrease glucose levels after eating (postprandial glucose).

INDICATIONS
Type 2 Diabetes
Dyed-bead-pancreas in (2) Tutu

Acarbose and miglitol are oral antidiabetics indicated for patients with type 2 diabetes uncontrolled by diet and exercise. These drugs may be administered alone or with insulin, metformin, or sulfonylureas. By decreasing carbohydrate absorption, these medications improve overall glycemic control by lowering postprandial blood glucose levels as well as hemoglobin A1C levels (refer to Picmonic "Hemoglobin A1C Lab Value").

SIDE EFFECTS
Flatulence
Farting

Since acarbose and miglitol decrease carbohydrate absorption, bacteria and digestive enzymes ferment leftover carbohydrates in the colon. The buildup of gas may cause abdominal distention and is released as flatulence. This is common in the first few days and should decrease with continued use.

Diarrhea
Toilet

Since these medications decrease glucose digestion, some carbohydrates remain undigested when entering the colon. Diarrhea is the byproduct of bacterial fermentation of complex carbohydrates in the colon. Instruct the patient to avoid sugary foods and to drink fluids for fluid replacement.

Anemia
Anemone

Acarbose and miglitol decrease the small intestine's ability to absorb iron. A lack of iron prevents the body from creating enough red blood cells and the patient may develop anemia. Assess the patient's hemoglobin and hematocrit levels and monitor the oxygen saturation.

Cramps
Clamps

These drugs alter normal digestion and may cause cramps. Inform the patient that stomach pains will decrease as the body adjusts to these medications. Gradually increasing the initial dose may improve drug tolerance.

CONSIDERATIONS
Monitor LFTs
Monitor Liver-with-test-tubes

Monitor the patient's liver function tests (AST, ALT) every three months during the first year of therapy and periodically after, as long term therapy may lead to liver dysfunction. Discontinuing acarbose will reverse liver damage. Liver dysfunction has not been found with miglitol administration.

Oral Glucose for Hypoglycemia
Oral Glue-bottle for Hippo-glue-bottle

Administering an alpha glucosidase inhibitor with insulin or a sulfonylurea may cause hypoglycemia. Give the patient glucose. Do not give the hypoglycemic patient sucrose because alpha glucosidase inhibitors interfere with sucrose hydrolysis and delay its effects. Examples of sucrose include fruit juice and starchy carbohydrates.

Unlock all 9 facts & definitions with Picmonic Free!

JOIN FREE

Take the Acarbose (Precose) and Miglitol (Glyset) (Alpha Glucosidase Inhibitors) Quiz

Picmonic's rapid review multiple-choice quiz allows you to assess your knowledge.

START QUIZ NOW

It's worth every penny

Our Story Mnemonics Increase Mastery and Retention

Memorize facts with phonetic mnemonics

Unforgettable characters with concise but impactful videos (2-4 min each)

Ace Your Nursing (RN) Classes & Exams with Picmonic:

Over 870,000 students use Picmonic’s picture mnemonics to improve knowledge, retention, and exam performance.

Choose the #1 Nursing (RN) student study app.

Picmonic for Nursing (RN) covers information that is relevant to your entire Nursing (RN) education. Whether you’re studying for your classes or getting ready to conquer your NCLEX®-RN, Hesi, ATI, TEAS test, Kaplan exams, we’re here to help.

Works better than traditional Nursing (RN) flashcards.

Research shows that students who use Picmonic see a 331% improvement in memory retention and a 50% improvement in test scores.